Paramount Skydance is demanding a $1.88 billion bond from states challenging its $110 billion merger with Warner Bros. Discovery, citing costs from the delay. The merger, which combines major film studios and streaming platforms, has regulatory approval but faces a lawsuit from a dozen states. The delay, now extended to June 2027, could cost Paramount up to $650 million per quarter in ticking fees paid to WBD shareholders. Paramount warns that without security for these costs, even winning the case won't recover the losses, and a failed deal would trigger a $7 billion breakup fee.
Argenx's stock surged 16.66% following positive Phase III ALKIVIA trial results for its autoimmune drug Vyvgart Hytrulo, showing significant efficacy in treating autoimmune myositis. Analyst firm William Blair reaffirmed an 'Outperform' rating, refle...
InspireMD reported better-than-expected Q2 results with a loss per share of -$0.17, improving from last year and beating estimates. Revenue reached $1.77 million, driven by strong 21% growth in international markets for its CGuard platform. The compa...
EyePoint Pharmaceuticals' stock dropped sharply after its wet AMD drug DURAVYU missed the primary trial endpoint, though an adjusted analysis showed it matched the standard treatment and cut treatment burden by 42%. Despite the setback, a Jefferies a...
H World Group reported better-than-expected Q2 2026 results, with earnings per share of $0.78 surpassing the $0.74 estimate and revenue of $1.05 billion exceeding forecasts. The company saw a 10.8% year-over-year revenue increase, driven mainly by a ...
Rocket Lab successfully launched eight satellites for MDA Space as part of a $143 million deal, boosting revenue to $234.07 million, above analyst expectations. Despite this operational success, the company reported a negative EPS of -$0.08, missing ...
